Skip to main content

HSBC HOLDINGS PLC

Position in NVAX — Novavax Inc

CIK 873630 LONDON, X0

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$414,159
+$262,528 QoQ
Shares Held
43,966
+136.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#102
of 263 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$143,070,000
PutShares
1,000,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. NVAX ranks #76 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $414,159 43,966
2026-03-31 $151,631 18,628
2025-12-31 $395,007 58,781
2025-03-31 $114,187 17,814
2024-12-31 $144,165 17,931
2024-09-30 $133,713 10,587
2024-06-30 $294,534 23,265
2024-03-31 $109,681 22,946
2023-12-31 $70,852 14,761
2023-09-30 $106,869 14,761
2023-06-30 $140,137 18,861
2023-03-31 $137,269 19,808
2022-12-31 $216,527 21,063
2022-09-30 $676,403 37,165
2022-06-30 $1,943,591 37,791
2022-03-31 $6,663,262 90,472
2021-12-31 $143,070,000 1,000,000
2021-12-31 $144,535,894 1,010,246
2021-09-30 $5,558,395 26,812
2021-06-30 $4,455,749 20,987
2021-03-31 $841,096 4,639
2020-12-31 $1,334,105 11,964
2020-09-30 $217,025 2,003
2020-06-30 $524,271 6,290